高血圧患者におけるピオグリタゾンの効果

基本情報

NCT ID

NCT01472497

ステータス

完了

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

16

治験依頼者名

Tottori University Hospital

概要

Insulin resistance is often complicated with hypertension. AGE and inflammation play important roles in insulin resistance. Some studies reported that pioglitazone, insulin sensitizer, is effective for patients with insulin resistance, however, the mechanisms are still unclear. The aim of this study to evaluate the effect of pioglitazone compared with glimepiride on AGE, inflammatory cytokines and cardiac markers (BNP and echo) in hypertensive patients during oral glucose tolerance test.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)